Publications by authors named "E F Goodfellow"

Claim this Profile
T
The PLK4 inhibitor RP-1664 demonstrates potent single-agent efficacy in neuroblastoma models through a dual mechanism of sensitivity.
John Maris, Isabel Soria-Bretones, Matias Casás-Selves, Minu Samanta, David Groff, Elliot Goodfellow Goodfellow

Res Sq· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 Inhibitor.
Frédéric Vallée, Matias Casás-Selves, Monica Bubenik, Martin Duplessis, Boubacar Sow, Elliot Goodfellow

J Med Chem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MICAL2 Promotes Pancreatic Cancer Growth and Metastasis.
Bharti Garg, Sohini Khan, Asimina S Courelli, Ponmathi Panneerpandian, Deepa Sheik Pran Babu, Elliot Goodfellow

Cancer Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MICAL2 Is a Super Enhancer Associated Gene that Promotes Pancreatic Cancer Growth and Metastasis.
Bharti Garg, Sohini Khan, Deepa Sheikh Babu, Evangeline Mose, Kevin Gulay, Elliot Goodfellow

bioRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Synthesis of a Trifunctional Molecular System "Programmed" to Block Epidermal Growth Factor Receptor Tyrosine Kinase, Induce High Levels of DNA Damage, and Inhibit the DNA Repair Enzyme (Poly(ADP-ribose) Polymerase) in Prostate Cancer Cells.
Julie Schmitt, Shanlong Huang, Elliot Goodfellow, Christopher Williams, Bertrand J Jean-Claude

J Med Chem· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis